Partnership

UNC Chapel Hill x GSK HIV Cure Research Partnership

UNC Chapel Hill and GlaxoSmithKline established a partnership to create a dedicated HIV cure research center on campus and a jointly owned company called Qura Therapeutics. The collaboration focuses on scientific approaches to curing HIV including novel therapeutic strategies.

development · Active · verified

Track UNC Chapel Hill x GSK HIV Cure Research Partnership

Machine-readable surfaces

Markdown mirror: /partnerships/unc-chapel-hill-x-gsk-hiv-cure-research-partnership.md
JSON-LD: embedded in this page’s head
REST API: /v1/partnerships/unc-chapel-hill-x-gsk-hiv-cure-research-partnership
Revision history: /partnerships/unc-chapel-hill-x-gsk-hiv-cure-research-partnership/history
Data documentation: /data
Query this programmatically: Deploy MCP

20422c86-7d89-4455-8473-1db62e7177ee

Parties (2)

University of North Carolina at Chapel Hill co developer
GlaxoSmithKline off-registry co developer

Sources (1)

https://searchiv.web.unc.edu/unc-gsk-partnership/

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.